Skip to content

Medical Guide

Med Select Bioresonance Device: Programs, Regulation, and Clinical Use

A guide explaining the SIT, regulation, frequency, and support programs of the Med Select bioresonance device, along with its objectives of use, safety, and clinical monitoring approach.

Short answerMed Select is covered in this guide for those who wish to learn about applications offered with the bioresonance approach. Personal goals and suitability are evaluated with a physician; as it has not been confirmed by sufficient clinical research that bioresonance treats diseases, standard care is maintained.

What is Med Select?

Med Select is presented by its manufacturer as a therapeutic system that combines bioresonance, System Information Therapy (SIT), and frequency/homeopathic programs. Its program library includes application options associated with regulation, stress, allergy, pain, detox, and various chronic complaints.

“Regulation” and the self-healing approach

The manufacturer uses the concepts of “self-healing” and regulation to describe an approach aimed at supporting the body’s physiological balance responses. In clinical practice, it is more appropriate to consider these concepts not as definitive results that automatically treat a specific organ or disease, but rather as therapeutic goals that must be evaluated alongside the individual’s symptoms, lifestyle, and response to sessions.

Detox and antimicrobial programs

The detox or microorganism-focused programs in the device are frequency-based complementary application topics. When there is suspicion of a clinical infection or toxic exposure, laboratory and toxicological methods are additionally used as needed; thus, frequency applications are interpreted within the individual’s actual medical context.

Use in allergies and chronic complaints

Bioresonance is used with different protocols for allergic complaints, pain, stress, and chronic symptoms. Because the extent of human data varies depending on the indication, it is important to establish measurable goals before the session and monitor changes in symptoms, function, and quality of life after the application.

SI cards and post-session support

The manufacturer defines SI cards as a method intended to allow application information to accompany the individual even after the session. When this approach is chosen, expectations are clearly explained to the individual; outcomes are evaluated based on clinical targets to be monitored rather than as guarantees.

Regulatory information

The manufacturer uses Class 2A and CE marking designations for Med Select. This information defines the technical and regulatory framework of the device; its clinical contribution in a specific disease is evaluated in conjunction with available human studies, the individual’s condition, and the application objective.

Our approach at our Bodrum clinic

When using Med Select, we first evaluate the individual’s reason for presentation, medications, current diagnoses, and goals. We select the application program according to this clinical context and monitor the contribution of the sessions as much as possible through changes in symptoms and function.

Scientific evidence and related guides

To compare human studies, study designs, and the limitations of evidence in the field of bioresonance, you can review the Bioresonance Human Studies: Evidence Map page. The Bioresonance main guide can be used for the clinical practice approach, and the Bioresonance showcase for topic clusters.

Written and medically reviewed by: Dr. Kerem Çağlayan
Last medical review: September 27, 2026

Notice: Device outputs alone do not substitute for a medical diagnosis. In case of clinical suspicion, standard diagnostic methods and physician evaluation are essential.

Editorial and Medical Review Policy

Medical editorial information

This content has been medically reviewed and approved by Dr. Kerem Çağlayan. It is intended for general education and does not replace an individual diagnosis or treatment plan.